NCT05213767 2022-01-28
Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
Clinical Trials
3 trialsNCT05061628 2021-09-29
The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Unknown
NCT03908814 2019-10-31
Phase I Clinical Trial of Human Anti-PD-L1 Antibody Injection (LDP) in Patients With Advanced Malignant Tumors
Dragonboat Biopharmaceutical Company Limited
Phase 1 Unknown